title: [Pharmacologic modification of cerebral activity: value of functional neuroimaging].
authors.affiliation: INSERM U455 et Fédération de Neurologie, Hôpital Purpan, Place Baylac, 31059 Toulouse, France.
authors.forename: F
authors.initials: F
authors.lastname: Chollet
authors.forename: I
authors.initials: I
authors.lastname: Loubinoux
authors.forename: J
authors.initials: J
authors.lastname: Pariente
authors.forename: C
authors.initials: C
authors.lastname: Carel
authors.forename: J F
authors.initials: JF
authors.lastname: Albucher
authors.forename: O
authors.initials: O
authors.lastname: Rascol
authors.forename: B
authors.initials: B
authors.lastname: Guiraud-Chaumeil
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D001931:Brain Mapping; D002544:Cerebral Infarction / Q000503:physiopathology; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D018377:Neurotransmitter Agents / Q000378:metabolism; D010300:Parkinson Disease / Q000503:physiopathology; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000502:physiology
chemical_list: D018377:Neurotransmitter Agents; D017981:Receptors, Neurotransmitter